Zobrazeno 1 - 10
of 738
pro vyhledávání: '"anti-seizure medication"'
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-13 (2024)
Abstract Background Neuropsychiatric comorbidities in adult patients with new-onset epilepsy in our university hospitals has not been assessed, so the purpose of this study was to identify the neuropsychiatric comorbidities in adult patients with new
Externí odkaz:
https://doaj.org/article/f677990ad0b747e58a067aa17f8ae4a4
Publikováno v:
Neurology International, Vol 16, Iss 4, Pp 880-890 (2024)
Population-based data on drug-resistant epilepsy (DRE) are lacking. This retrospective study aimed to determine the prevalence and incidence of pediatric epilepsy and DRE in South Korea using health insurance claims data from the Health Insurance Rev
Externí odkaz:
https://doaj.org/article/ed9f2c811de8428ea5bc99dbfb04432f
Autor:
Pengxia Wu, Qingzhu Liu, Xianyu Liu, Yu Sun, Jie Zhang, Ruofan Wang, Taoyun Ji, Shuang Wang, Xiaoyan Liu, Yuwu Jiang, Lixin Cai, Ye Wu
Publikováno v:
Epilepsia Open, Vol 9, Iss 4, Pp 1480-1492 (2024)
Abstract Objective To provide evidence for choosing surgical or nonsurgical treatment for epilepsy in patients with unilateral multilobar and hemispheric polymicrogyria (PMG). Methods We searched published studies until September 2022 related to unil
Externí odkaz:
https://doaj.org/article/512f0d3951944d33ac93e5d1827aad38
Autor:
Sangeeta Ravat, Anshu Rohatgi, Rahul Kulkarni, Shaik A. Jabeen, Balaji Patil, Amitabh Dash, Manoj Malhotra
Publikováno v:
Epilepsia Open, Vol 9, Iss 3, Pp 940-950 (2024)
Abstract Objective ESPRITE (Study 508; NCT03836924) evaluated the real‐world safety, tolerability, and efficacy of adjunctive perampanel in patients aged ≥12 years with focal‐onset seizures (FOS), with or without focal to bilateral tonic–clon
Externí odkaz:
https://doaj.org/article/53a7fbc76d764f7caf95cd712768f626
Autor:
Mohammad Mofatteh, Saman Arfaie, Mohammad Sadegh Mashayekhi, Phillip L. Pearl, Sunit Das, Aaron Cohen-Gadol
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/9e4a53f9694044fcb02be404251fd30a
Autor:
Eric Witherspoon, Nicholas Zuczek, Gabrielle Williams, Briana Bernstein, Anjik Ghosh, Marko Culjat, Suhasini Kaushal, Patrick A. Forcelli
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
IntroductionExposure to a range of anti-seizure medications (ASMs) during early brain development adversely impacts neurodevelopmental outcomes in both animal models and in clinical studies. Many ASMs, including phenobarbital, phenytoin, valproate (V
Externí odkaz:
https://doaj.org/article/9959f71ca64c463db4add9fe3d231bb9
Autor:
Lisa Lappe, Christoph Hertzberg, Susanne Knake, Markus Knuf, Felix von Podewils, Laurent M. Willems, Stjepana Kovac, Johann Philipp Zöllner, Matthias Sauter, Gerhard Kurlemann, Thomas Mayer, Astrid Bertsche, Klaus Marquard, Sascha Meyer, Hannah Schäfer, Charlotte Thiels, Bianca Zukunft, Susanne Schubert-Bast, Jens-Peter Reese, Felix Rosenow, Adam Strzelczyk
Publikováno v:
Neurological Research and Practice, Vol 6, Iss 1, Pp 1-16 (2024)
Abstract Background Depending on the underlying etiology and epilepsy type, the burden of disease for patients with seizures can vary significantly. This analysis aimed to compare direct and indirect costs and quality of life (QoL) among adults with
Externí odkaz:
https://doaj.org/article/94a1beec63544a8daacfdb13185ad09d
Autor:
Louise Linka, Benedikt Magnus, Nabard Faiz, Lena Habermehl, Panagiota-Eleni Tsalouchidou, Felix Zahnert, Leona Moeller, Kristina Krause, Susanne Knake, Katja Menzler
Publikováno v:
Neurological Research and Practice, Vol 6, Iss 1, Pp 1-8 (2024)
Abstract Background The risk of seizure recurrence after a first unprovoked epileptic seizure is reported to be approximately 40%. Little is known about the recurrence risk after a first seizure in elderly patients, who may be at higher risk due to a
Externí odkaz:
https://doaj.org/article/b8e333723eea48c7a64f221ea4678520
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundThe management of epilepsy is mainly based on antiseizure medications (ASMs). More than 20 ASMs have been introduced in clinical practice, providing a multitude of prescription choices. To date, there are no published data on the trends in
Externí odkaz:
https://doaj.org/article/2859f18043134653a26b307ffaa2f2ed
Publikováno v:
Frontiers in Network Physiology, Vol 4 (2024)
Epilepsy is a neurological disorder characterized by recurrent seizures, affecting over 65 million people worldwide. Treatment typically commences with the use of anti-seizure medications, including both mono- and poly-therapy. Should these fail, mor
Externí odkaz:
https://doaj.org/article/26cca26f1c51415f93382d52d5c00f78